Sunil Bhandari Hull & East Yorkshire Hospitals NHS Trust United Kingdom

• STOP-ACEi Study
  Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
• Q and A
• DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
  Natalie Staplin Free Communication University of OxfordUnited Kingdom
• Q and A
• SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
  Muh Geot Wong Speaker University of SydneyAustralia
• Q and A
• RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
  Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
• Q and A